RxSight, Inc. (RXST)
NASDAQ·Healthcare·Medical - Devices
$7.19
-1.37%
Mkt Cap $299.18M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $30.17M | $32.61M | +8.09% | -$0.33 | -$0.22 | +34.27% | — | — |
| Q4 2025 Nov 5, 2025 | $32.60M | $30.34M | -6.94% | -$0.19 | -$0.04 | +78.95% | — | — |
| Q3 2025 Aug 7, 2025 | $25.75M | $33.64M | +30.64% | -$0.10 | -$0.08 | +20.00% | — | — |
| Q2 2025 May 7, 2025 | $37.91M | $37.90M | -0.03% | -$0.04 | -$0.03 | +25.00% | — | — |
| Q1 2025 Feb 25, 2025 | $39.78M | $40.21M | +1.09% | $0.10 | $0.03 | -70.00% | — | — |
| Q4 2024 Nov 7, 2024 | $40.36M | $45.41M | +12.49% | -$0.25 | -$0.16 | +36.00% | — | — |
| Q3 2024 Aug 5, 2024 | $35.04M | $34.89M | -0.44% | -$0.22 | -$0.16 | +27.27% | — | — |
| Q2 2024 May 6, 2024 | $27.56M | $29.51M | +7.08% | -$0.17 | -$0.12 | +29.41% | — | — |
| Q1 2024 Feb 28, 2024 | $27.43M | $28.58M | +4.19% | -$0.36 | -$0.26 | +27.78% | — | — |
| Q4 2023 Nov 9, 2023 | $25.76M | $30.67M | +19.05% | -$0.42 | -$0.35 | +16.67% | — | — |
| Q3 2023 Aug 7, 2023 | $19.23M | $20.81M | +8.22% | -$0.47 | -$0.40 | +14.89% | — | — |
| Q2 2023 May 9, 2023 | $19.23M | $17.49M | -9.05% | -$0.52 | -$0.42 | +19.23% | — | — |
| Q1 2023 Mar 6, 2023 | $16.28M | $16.09M | -1.18% | -$0.72 | -$0.56 | +22.22% | — | — |
| Q4 2022 Nov 7, 2022 | $10.98M | $12.62M | +14.91% | -$0.70 | -$0.61 | +12.86% | — | — |
| Q3 2022 Aug 8, 2022 | $10.55M | $11.36M | +7.68% | -$0.68 | -$0.50 | +26.47% | — | — |
| Q2 2022 May 5, 2022 | $7.32M | $8.94M | +22.17% | -$0.56 | -$0.54 | +3.57% | — | — |
| Q1 2022 Mar 8, 2022 | $7.64M | $8.43M | +10.30% | -$0.58 | -$0.47 | +18.97% | — | — |
| Q4 2021 Nov 10, 2021 | $5.46M | $5.79M | +5.88% | -$0.61 | -$0.65 | -6.56% | — | — |
| Q3 2021 Sep 9, 2021 | — | $4.90M | — | -$0.68 | -$3.24 | -376.47% | — | — |
| Q3 2021 Jul 30, 2021 | — | $3.48M | — | — | -$0.36 | — | — | — |